---
title: 'Molnupiravir: A New Hope For Prevention And Treatment Of Covid-19 And Other
  Dangerous Viruses'
date: "2021-03-16 17:06:31"
author: Forbes - Innovation
authorlink: https://www.forbes.com/sites/williamhaseltine/2021/03/16/molnupiravir-a-new-hope-for-prevention-and-treatment-of-covid-19-and-other-dangerous-viruses/
tags:
- Forbes-Innovation
---
A new Covid-19 therapy has completed its phase two human trial and the results are promising. Molnupiravir, developed by Ridgeback Biotherapeutics LP and Merck & Co., reached its endpoint objective of reducing the length of Covid-19 infections, according to a Merck press release.